AI assistant
GABELLI MERGER PLUS+ TRUST PLC — Director's Dealing 2020
Aug 7, 2020
4983_dirs_2020-08-07_041c2537-0b9a-4551-995f-23f001c014cf.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
RNS Number : 5401V
Gabelli Merger Plus+ Trust PLC
07 August 2020
GABELLI MERGER PLUS+ TRUST PLC
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE REGULATIONS
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Mr Marc Gabelli
2
Reason for the notification
a)
Position/status
CHAIRMAN & NON-EXECUTIVE DIRECTOR
b)
Initial notification /Amendment
Initial
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Gabelli Merger Plus+ Trust Plc
b)
LEI
5493006X09N8HK0V1U37
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of $0.01 per share
GB00BD8P0741
b)
Nature of the transaction
Two share purchases
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| (1) USD 6.50 (2) USD 6.50 |
5,000 5,000 |
d)
Aggregated information
- Aggregated volume
- Price
- Total value of transactions
- Cumulative holding
10,000
USD 6.50 per share
USD 65,000
20,000
e)
Date of the transaction
(1) 31 July 2020
(2) 3 August 2020
f)
Place of the transaction
London
For further information, please contact:
| Maitland Administration Services Limited | [email protected] |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHBXGDILSGDGGR